| Product ID |
CAS Number |
Product Name |
Quantity |
| A1-0117 |
193269-78-2 |
1-BOC-3-Aminoazetidine |
|
| AS-1718 |
2034-22-2 |
2,4,5-Tribromoimidazole |
|
| AS-3747 |
5453-67-8 |
DIMETHYL 2,6-PYRIDINEDICARBOXYLATE |
|
| AS-3811 |
594-61-6 |
2-Hydroxyisobutyric acid |
|
| AS-4438 |
21423-84-7 |
2-CHLORO-4-METHYLBENZONITRILE |
|
| AS-6642 |
68077-26-9 |
1-ETHYL-7-CHLORO-6-FLUORO-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXYLIC ACID |
|
| AS-7433 |
6299-85-0 |
2-(3-CHLOROPHENYL)MALONDIALDEHYDE |
|
| AS-9127 |
5470-65-5 |
3-Bromo-4-nitrophenol |
|
| BTC-0001 |
156072-86-5 |
5-Bromo-3-methylpyridine-2-carbonitrile |
|
| JR02-H082 |
66346-85-8 |
3-Chloro-6-pyrrolidin-1-yl-pyridazine |
|
| JR6-L1916 |
1132702-00-1 |
Benzeneethanol, 4-bromo-2,5-dimethoxy-a-methyl-, (aS)- |
|
| JR6-L2484 |
148527-65-5 |
Benzoic acid, 2-(2,2,2-trifluoro-1-hydroxyethyl)- |
|
| JR6-L2972 |
1243142-31-5 |
5-Thiazolecarboxylic acid, 4-chloro-2-(4-chlorophenyl)-, methyl ester |
|
| JR6-L3603 |
1271635-08-5 |
2-(3-chloro-5-fluorophenyl)-1-(3,4-dimethylphenyl)ethanone |
|
| JR6-L3763 |
188698-46-6 |
1H-Imidazole-4-pentanal, 1-(triphenylmethyl)- |
|
| JR6-L4423 |
1089130-94-8 |
Pyrrolidine, 1-[(4-bromophenyl)methyl]-3-methoxy-, (3S)- |
|
| JR6-L6057 |
560113-08-8 |
3(2H)-Pyridazinone, 6-[2-amino-4-[methyl(phenylmethyl)amino]-6-phenyl-5-pyrimidinyl]-2-(1-methylethyl)- |
|
| JR6-L6575 |
4518-10-9 |
Methyl 3-aminobenzoate |
|
| JR6-L7214 |
57980-08-2 |
1,8-Naphthyridin-2(1H)-one, 7-amino-4-(trifluoromethyl)- |
|
| JR6-L7628 |
263718-60-1 |
2-Pyridinemethanamine, 6-bromo-a-methyl-, (aR)- |
|
| JR6-L7978 |
1344612-19-6 |
(S)-3-amino-5-bromo-2-oxoindoline-3-carboxylic acid |
|
| JR6-L9329 |
1212895-83-4 |
Benzonitrile, 4-(2S)-2-piperidinyl- |
|
| JR6-L9338 |
1430060-17-5 |
1,3-Bis[(1R)-2,2-dimethyl-1-(1-naphthyl)propyl]imidazolium iodide |
|
| JR6-L9535 |
517-22-6 |
2,4-Dimethyl-3-ethylpyrrole |
|
| JR6-L9552 |
1104636-73-8 |
6-Methyl-2-vinyl-1,3,6,2-dioxazaborocane-4,8-dione |
|
| JR8-N0088 |
491-70-3 |
luteolin |
|
| JR8-N0169 |
40246-10-4 |
Glycitin |
|
|
|
|
|
|
|
|
|
|
|
|
|